Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

7320

Potential Effects Of Sodium Reformulation On Dementia Burden In Australia: A Modelling Study

Part of Topic

Potential Effects Of Sodium Reformulation On Dementia Burden In Australia: A Modelling Study

Introduction: 

Mid-life high blood pressure increases dementia risk (1,2). Sodium reduction is an established strategy to lower blood pressure, targeting cardiovascular disease burden (3,4). However, potential benefits in terms of  population level dementia risk and burden remain under researched. 

The aim of the present study was to estimate the health effect of population level sodium reduction for the dementia syndrome in Australia, by 1) mandating the World Health Organization (WHO) sodium benchmarks for packaged foods (5) and 2) mandating the current voluntary Australian Healthy Food Partnership (HFP) targets (6). 

Methods: 

A proportional multistate lifetable model (7) was used to simulate dementia specific effects of 1) mandatory WHO sodium benchmarks (apply to 58 food groups) (5), and 2) mandatory HFP targets (apply to 27 food groups) (6), versus current packaged-food sodium levels. Blood pressure and dementia data came from the 2019 Global Burden of Disease Study (8). The effect of sodium reduction on blood pressure and blood pressure on dementia risk was modelled based on meta-analyses of randomised trials (2,4). Outcomes were incident dementia cases averted and health adjusted life years (HALYs) gained among Australians aged 20+ years, at 10 years and over the population lifetime.

Results: 

Preliminary Findings: Mandating WHO benchmarks could avert 4,123 (95% uncertainty interval 2,227 to 6,421) dementia cases and gain 2,125 (1,180 to 3,344) HALYs by 10 years. Over the population lifetime, an estimated 48,101 (27,903 to 70,925) cases could be averted and 34,528 (19,900 to 50,880) HALYs gained. Lifetime HALY gains were approximately 60% higher for females than males. Health gains were significantly higher when applying the WHO benchmarks, in comparison to the Australian HFP targets, Figure.

Conclusion: 

Mandatory sodium reformulation in line with the WHO sodium benchmarks could prevent nearly 50,000 lifetime dementia cases in Australia, with significantly greater projected health gains in comparison to mandating current Australian HFP targets. These findings highlight dementia prevention as an additional rationale for stronger sodium regulation beyond cardiovascular disease benefits.

References: 

1.Livingston G, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452):572–628.
2.Peters R, et al. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. European Heart Journal. 2022;43(48):4980–90.
3.World Health Organization. Tackling NCDs: 'best buys' and other recommended interventions for the prevention and control of noncommunicable diseases. World Health Organization; 2017
4.Huang L, et al. Effect of dose and duration of reduction in dietary sodium on blood pressure levels: systematic review and meta-analysis of randomised trials. BMJ. 2020;368
5.World Health Organization. WHO Global Sodium Benchmarks for Different Food Categories. Geneva, Switzerland: World Health Organization; 2021.
6.Department of Health Disability and Ageing. Partnership Reformulation Program: Australian Government 2025
7.Marklund M, et al. Estimated health effect, cost, and cost-effectiveness of mandating sodium benchmarks in Australia's packaged foods: a modelling study. The Lancet Public Health. 2024;9(11):e861–e70
8.Vos T, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1204–22.

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.